Lianmei Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lianmei Jiang has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Yong Chen
Sorbonne Université, CNRS
6 shared publications Jiannong Ye
E China Normal Univ, Dept Chem, Shanghai 200062, Peoples R China
5 shared publicationsJ.J. Li
Ecole Normale Supérieure, CNRS-ENS-UPMC UMR 8640, 24 rue Lhomond, 75231 Paris, France
3 shared publicationsJian Shi
CNRS ENS UPMC UMR 8640, Ecole Normale Super, F-75005 Paris, France
3 shared publicationsQingcui Chu
3 shared publications- Ada Hang-Heng Wong
John Wiley & Sons (United States)
2 shared publications
Latest Publications
- Open Access
- 24 March 2022
- Published by Oxford University Press (OUP) in Antibody Therapeutics
- Vol. 5 (2) , 85-99
Assessment of chimeric antigen receptor T cytotoxicity by droplet microfluidics in vitro
Chimeric antigen receptor T (CAR-T) cells are cytotoxic T cells engineered to specifically kill cancer cells expressing specific target receptor(s). Prior CAR-T efficacy tests include CAR expression analysis by qPCR or ELISA, in vitro measurement of interferon-γ (IFNγ) or interleukin-2 (IL-2), and xenograft models. However, the in vitro measurements did not reflect CAR-T cytotoxicity, whereas xenograft models are low throughput and costly. Here, we presented a robust in vitro droplet microfluidic assay for CAR-T cytotoxicity assessment. This method not only enabled assessment of CAR-T cytotoxic activity under different fluid viscosity conditions, but also facilitated measurement of CAR-T expansion and dissection of mechanism of action via phenotype analysis in vitro. Furthermore, our data suggested that label-free cytotoxicity analysis is feasible by acquiring data before and after treatment. Hence, this study presented a novel in vitro method for assessment of cellular cytotoxicity that could potentially be applied to any cytotoxicity experiment with varying solvent composition.
- 24 March 2022
- Published by Oxford University Press (OUP) in Antibody Therapeutics
- Vol. 5 (2) , 85-99
Open AccessAssessment of chimeric antigen receptor T cytotoxicity by droplet microfluidics in vitro
Chimeric antigen receptor T (CAR-T) cells are cytotoxic T cells engineered to specifically kill cancer cells expressing specific target receptor(s). Prior CAR-T efficacy tests include CAR expression analysis by qPCR or ELISA, in vitro measurement of interferon-γ (IFNγ) or interleukin-2 (IL-2), and xenograft models. However, the in vitro measurements did not reflect CAR-T cytotoxicity, whereas xenograft models are low throughput and costly. Here, we presented a robust in vitro droplet microfluidic assay for CAR-T cytotoxicity assessment. This method not only enabled assessment of CAR-T cytotoxic activity under different fluid viscosity conditions, but also facilitated measurement of CAR-T expansion and dissection of mechanism of action via phenotype analysis in vitro. Furthermore, our data suggested that label-free cytotoxicity analysis is feasible by acquiring data before and after treatment. Hence, this study presented a novel in vitro method for assessment of cellular cytotoxicity that could potentially be applied to any cytotoxicity experiment with varying solvent composition.
- Open Access
Assessment of chimeric antigen receptor T (CAR-T) cytotoxicity by droplet microfluidics in vitro
Chimeric antigen receptor T (CAR-T) cells are cytotoxic T cells engineered to specifically kill cancer cells expressing specific target receptor(s). Prior CAR-T efficacy tests include CAR expression analysis by qPCR or ELISA, in vitro measurement of interferon-γ (IFNγ) or interleukin-2 (IL-2), and xenograft models. However, the in vitro measurements did not reflect CAR-T cytotoxicity, whereas xenograft models are low throughput and costly. Here we presented a robust in vitro droplet microfluidic assay for CAR-T cytotoxicity assessment. This method not only enabled assessment of CAR-T cytotoxic activity under different fluid viscosity conditions, but also facilitated measurement of CAR-T expansion and dissection of mechanism of action via phenotype analysis in vitro . Furthermore, our data suggested that label-free cytotoxicity analysis is feasible by acquiring data before and after treatment. Hence, this study presented a novel in vitro method for assessment of cellular cytotoxicity that could potentially be applied to any cell-kill-cell experiment with varying solvent composition.
Open AccessAssessment of chimeric antigen receptor T (CAR-T) cytotoxicity by droplet microfluidics in vitro
Chimeric antigen receptor T (CAR-T) cells are cytotoxic T cells engineered to specifically kill cancer cells expressing specific target receptor(s). Prior CAR-T efficacy tests include CAR expression analysis by qPCR or ELISA, in vitro measurement of interferon-γ (IFNγ) or interleukin-2 (IL-2), and xenograft models. However, the in vitro measurements did not reflect CAR-T cytotoxicity, whereas xenograft models are low throughput and costly. Here we presented a robust in vitro droplet microfluidic assay for CAR-T cytotoxicity assessment. This method not only enabled assessment of CAR-T cytotoxic activity under different fluid viscosity conditions, but also facilitated measurement of CAR-T expansion and dissection of mechanism of action via phenotype analysis in vitro . Furthermore, our data suggested that label-free cytotoxicity analysis is feasible by acquiring data before and after treatment. Hence, this study presented a novel in vitro method for assessment of cellular cytotoxicity that could potentially be applied to any cell-kill-cell experiment with varying solvent composition.
- 6 October 2020
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 118 (2) , 647-658
Microdroplet enabled cultivation of single yeast cells correlates with bulk growth and reveals subpopulation phenomena
Yeast has been engineered for cost‐effective organic acid production through metabolic engineering and synthetic biology techniques. However, cell growth assays in these processes were performed in bulk at the population level, thus obscuring the dynamics of rare single cells exhibiting beneficial traits. Here, we introduce the use of monodisperse picolitre droplets as bioreactors to cultivate yeast at the single‐cell level. We investigated the effect of acid stress on growth and the effect of potassium ions on propionic acid tolerance for single yeast cells of different species, genotypes, and phenotypes. The results showed that the average growth of single yeast cells in microdroplets experiences the same trend to those of yeast populations grown in bulk, and microdroplet compartments do not significantly affect cell viability. This approach offers the prospect of detecting cell‐to‐cell variations in growth and physiology and is expected to be applied for the engineering of yeast to produce value‐added bioproducts.
- 6 October 2020
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 118 (2) , 647-658
Microdroplet enabled cultivation of single yeast cells correlates with bulk growth and reveals subpopulation phenomena
Yeast has been engineered for cost‐effective organic acid production through metabolic engineering and synthetic biology techniques. However, cell growth assays in these processes were performed in bulk at the population level, thus obscuring the dynamics of rare single cells exhibiting beneficial traits. Here, we introduce the use of monodisperse picolitre droplets as bioreactors to cultivate yeast at the single‐cell level. We investigated the effect of acid stress on growth and the effect of potassium ions on propionic acid tolerance for single yeast cells of different species, genotypes, and phenotypes. The results showed that the average growth of single yeast cells in microdroplets experiences the same trend to those of yeast populations grown in bulk, and microdroplet compartments do not significantly affect cell viability. This approach offers the prospect of detecting cell‐to‐cell variations in growth and physiology and is expected to be applied for the engineering of yeast to produce value‐added bioproducts.
- Open Access
- 15 January 2020
- Published by MDPI AG in Micromachines
- Vol. 11 (1) , 94
Improving Single-Cell Encapsulation Efficiency and Reliability through Neutral Buoyancy of Suspension
Single-cell analysis is of critical importance in revealing cell-to-cell heterogeneity by characterizing individual cells and identifying minority sub-populations of interest. Droplet-based microfluidics has been widely used in the past decade to achieve high-throughput single-cell analysis. However, to maximize the proportion of single-cell emulsification is challenging due to cell sedimentation and aggregation. The purpose of this study was to investigate the influence of single-cell encapsulation and incubation through the use of neutral buoyancy. As a proof of concept, OptiPrep™ was used to create neutrally buoyant cell suspensions of THP-1, a human monocytic leukemia cell line, for single-cell encapsulation and incubation. We found that using a neutrally buoyant suspension greatly increased the efficiency of single-cell encapsulation in microdroplets and eliminated unnecessary cell loss. Moreover, the presence of OptiPrep™ was shown to not affect cellular viability. This method significantly improved the effectiveness of single-cell study in a non-toxic environment and is expected to broadly facilitate single-cell analysis.
- 15 January 2020
- Published by MDPI AG in Micromachines
- Vol. 11 (1) , 94
Open AccessImproving Single-Cell Encapsulation Efficiency and Reliability through Neutral Buoyancy of Suspension
Single-cell analysis is of critical importance in revealing cell-to-cell heterogeneity by characterizing individual cells and identifying minority sub-populations of interest. Droplet-based microfluidics has been widely used in the past decade to achieve high-throughput single-cell analysis. However, to maximize the proportion of single-cell emulsification is challenging due to cell sedimentation and aggregation. The purpose of this study was to investigate the influence of single-cell encapsulation and incubation through the use of neutral buoyancy. As a proof of concept, OptiPrep™ was used to create neutrally buoyant cell suspensions of THP-1, a human monocytic leukemia cell line, for single-cell encapsulation and incubation. We found that using a neutrally buoyant suspension greatly increased the efficiency of single-cell encapsulation in microdroplets and eliminated unnecessary cell loss. Moreover, the presence of OptiPrep™ was shown to not affect cellular viability. This method significantly improved the effectiveness of single-cell study in a non-toxic environment and is expected to broadly facilitate single-cell analysis.
- 30 October 2017
- Published by AIP Publishing in Applied Physics Letters
- Vol. 111 (18)
A microfluidic needle for sampling and delivery of chemical signals by segmented flows
We have developed a microfluidic needle-like device that can extract and deliver nanoliter samples. The device consists of a T-junction to form segmented flows, parallel channels to and from the needle tip, and seven hydrophilic capillaries at the tip that form a phase-extraction region. The main microchannel is hydrophobic and carries segmented flows of water-in-oil. The hydrophilic capillaries transport the aqueous phase with a nearly zero pressure gradient but require a pressure gradient of 19 kPa for mineral oil to invade and flow through. Using this device, we demonstrate the delivery of nanoliter droplets and demonstrate sampling through the formation of droplets at the tip of our device. During sampling, we recorded the fluorescence intensities of the droplets formed at the tip while varying the concentration of dye outside the tip. We measured a chemical signal response time of approximately 3 s. The linear relationship between the recorded fluorescence intensity of samples and the external dye concentration (10–40 μg/ml) indicates that this device is capable of performing quantitative, real-time measurements of rapidly varying chemical signals.
- 30 October 2017
- Published by AIP Publishing in Applied Physics Letters
- Vol. 111 (18)
A microfluidic needle for sampling and delivery of chemical signals by segmented flows
We have developed a microfluidic needle-like device that can extract and deliver nanoliter samples. The device consists of a T-junction to form segmented flows, parallel channels to and from the needle tip, and seven hydrophilic capillaries at the tip that form a phase-extraction region. The main microchannel is hydrophobic and carries segmented flows of water-in-oil. The hydrophilic capillaries transport the aqueous phase with a nearly zero pressure gradient but require a pressure gradient of 19 kPa for mineral oil to invade and flow through. Using this device, we demonstrate the delivery of nanoliter droplets and demonstrate sampling through the formation of droplets at the tip of our device. During sampling, we recorded the fluorescence intensities of the droplets formed at the tip while varying the concentration of dye outside the tip. We measured a chemical signal response time of approximately 3 s. The linear relationship between the recorded fluorescence intensity of samples and the external dye concentration (10–40 μg/ml) indicates that this device is capable of performing quantitative, real-time measurements of rapidly varying chemical signals.
- 23 January 2016
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 35 (3) , 415-422
Digital antimicrobial susceptibility testing using the MilliDrop technology
We present the MilliDrop Analyzer (MDA), a droplet-based millifluidic system for digital antimicrobial susceptibility testing (D-AST), which enables us to determine minimum inhibitory concentrations (MICs) precisely and accurately. The MilliDrop technology was validated by using resazurin for fluorescence readout, for comparison with standard methodology, and for conducting reproducibility studies. In this first assessment, the susceptibility of a reference Gram-negative strain Escherichia coli ATCC 25922 to gentamicin, chloramphenicol, and nalidixic acid were tested by the MDA, VITEK®2, and broth microdilution as a reference standard. We measured the susceptibility of clinically relevant Gram-positive strains of Staphylococcus aureus to vancomycin, including vancomycin-intermediate S. aureus (VISA), heterogeneous vancomycin-intermediate S. aureus (hVISA), and vancomycin-susceptible S. aureus (VSSA) strains. The MDA provided results which were much more accurate than those of VITEK®2 and standard broth microdilution. The enhanced accuracy enabled us to reliably discriminate between VSSA and hVISA strains.
- 23 January 2016
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 35 (3) , 415-422
Digital antimicrobial susceptibility testing using the MilliDrop technology
We present the MilliDrop Analyzer (MDA), a droplet-based millifluidic system for digital antimicrobial susceptibility testing (D-AST), which enables us to determine minimum inhibitory concentrations (MICs) precisely and accurately. The MilliDrop technology was validated by using resazurin for fluorescence readout, for comparison with standard methodology, and for conducting reproducibility studies. In this first assessment, the susceptibility of a reference Gram-negative strain Escherichia coli ATCC 25922 to gentamicin, chloramphenicol, and nalidixic acid were tested by the MDA, VITEK®2, and broth microdilution as a reference standard. We measured the susceptibility of clinically relevant Gram-positive strains of Staphylococcus aureus to vancomycin, including vancomycin-intermediate S. aureus (VISA), heterogeneous vancomycin-intermediate S. aureus (hVISA), and vancomycin-susceptible S. aureus (VSSA) strains. The MDA provided results which were much more accurate than those of VITEK®2 and standard broth microdilution. The enhanced accuracy enabled us to reliably discriminate between VSSA and hVISA strains.
- 4 March 2013
- Published by Elsevier in Microelectronic Engineering
- Vol. 110, 365-368
Upside and downside views of adherent cells on patterned substrates: Three-dimensional image reconstruction
- 4 March 2013
- Published by Elsevier in Microelectronic Engineering
- Vol. 110, 365-368
Upside and downside views of adherent cells on patterned substrates: Three-dimensional image reconstruction
- 9 February 2013
- Published by Elsevier in Microelectronic Engineering
- Vol. 110, 70-74
Fabrication of gelatin nanopatterns for cell culture studies
- 9 February 2013
- Published by Elsevier in Microelectronic Engineering
- Vol. 110, 70-74
Fabrication of gelatin nanopatterns for cell culture studies
- 28 November 2012
- Published by Elsevier in Microelectronic Engineering
- Vol. 111, 262-266
Microfluidic capture of endothelial progenitor cells in human blood samples
- 28 November 2012
- Published by Elsevier in Microelectronic Engineering
- Vol. 111, 262-266
Microfluidic capture of endothelial progenitor cells in human blood samples
- 1 July 2012
- Published by Elsevier in Applied Surface Science
- Vol. 258 (19) , 7530-7535
Segmented magnetic nanofibers for single cell manipulation
- 1 July 2012
- Published by Elsevier in Applied Surface Science
- Vol. 258 (19) , 7530-7535
Segmented magnetic nanofibers for single cell manipulation